CoChat

Inflammatory Reaction in Neurological Diseases

Open access
Wang, Hung-Chen, Lu, Cheng-Hsien, Cheng, Kuang-I, Chiang, Jason Cheng-Hsuan · 2014 · BioMed Research International
Cited by 122

The DOI matches its Crossref record.

Abstract

Inflammatory reaction in the central nervous system (CNS) is now recognized to be a feature of all neurological disorders. In neurological degenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease (AD), there is prominent infiltration of various leukocyte subsets into the CNS or there is intense activation of microglia with resultant elevation of many inflammatory mediators within the CNS. In acute critical CNS diseases, such as delayed deterioration associated with vasospasm after subarachnoid hemorrhage (SAH), ischemic stroke, spontaneous intracerebral hemorrhage (ICH), and traumatic brain injury (TBI), recent evidences show that inflammation may be a potential target for therapy. Inflammation has become a promising area of research for new treatments. To accelerate the process of translating this information to clinical applications, a number of important issues must be addressed such as their ability to consistently detect characteristic cerebral deficits in individuals with neurological degenerative diseases, the relationships of cerebral injuries to clinical symptoms and genetic characteristics, and the degree to which these injuries respond to different therapies. In this special issue, several research groups report findings that address some of these issues. In neurological degenerative diseases, the paper by C. Millington et al. reviewed the role of chronic neuroinflammation in the pathogenesis of Alzheimer's disease (AD). With the glial fibrillary acidic protein-interleukin 6 (GFAP-IL6) transgenic mice model, the authors found that this animal model, in which chronic neuroinflammation triggered constitutive expression of the cytokine interleukin-6 (IL-6) in astrocytes, could serve as an excellent tool for drug discovery and validation in vivo. The paper by X. Su and H. J. Federoff reviewed the role of inflammation in Parkinson's disease (PD) neuropathology. They provide an overview of current knowledge on the temporal profile of central and peripheral immune responses in PD and discuss the potential synergistic effects of the central and peripheral inflammation in disease development. The study by W.-C. Lin et al. used TRODAT-1 SPECT to evaluate leukocyte apoptosis in PD patients and its association with central dopamine neuron loss. The leukocyte apoptosis and striatal dopamine transporter uptake ratios were further associated with increased severity and longer duration of disease. The interaction between brain and systemic inflammation may be responsible for the neurodegenerative disease progression. The paper by K. Lu et al. used the Longitudinal Health Insurance Database 2000 (LHID2000) to investigate and compare the risk of dementia between patients clinically diagnosed with autoimmune rheumatic diseases (ARD) and non-ARD patients during a 5-year follow-up period. Their findings suggest that patients with and without ARD were found to have similar risks of developing dementia. In acute critical CNS diseases, the study by K.-W. Wang et al. used traumatic brain injury (TBI) model to determine whether simvastatin combined with an antioxidant could attenuate cerebral vascular endothelial inflammatory response after traumatic brain injury in rat. Their findings support that simvastatin combined with an antioxidant could provide neuroprotection and it may be attributed to a dampening of cerebral vascular endothelial inflammatory response. The study by W. Winardi et al. used a structural equation modeling to evaluate the predictive value of admission Glasgow Coma Scale (GCS) scores, duration of unconsciousness, neurosurgical intervention, and countercoup lesion on the impairment of memory and processing speed functions six months after a TBI. The study demonstrated that admission GCS score is a robust predictor of memory/processing speed dysfunctions after TBI. The study by N.-W. Tsai et al. investigated serum thiobarbituric acid-reactive substances (TBARS) and free thiol levels in different subtypes of acute ischemic stroke (AIS) and evaluated their association with clinical outcomes. They found that patients with large-vessel disease have higher oxidative stress but lower antioxidant defense compared to those with small-vessel disease after AIS. Serum TBARS level at the acute phase of stroke is a potential predictor for three-month outcome. And the paper by C.-M. Su et al. aimed to determine whether serum adhesion molecules are associated with septic encephalopathy (SE). Their findings demonstrate that SE implies higher mortality in nontraumatic, nonsurgical patients with severe sepsis. Serum vascular cell adhesion molecule-1 (VCAM-1) level on presentation is a more powerful predictor of SE in these patients than lactate concentration and other adhesion molecules on admission. In the CNS malignancy, the study by D. Winardi et al. investigated the relationship between protein expressions of two autophagy markers, LC3B and Beclin-1, with clinical parameters in astrocy

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2014/408514

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 122

Metadata

Authors
Wang, H.-C., Lu, C.-H., Cheng, K.-I., & Chiang, J. C.-H.
Venue
BioMed Research International
Published
2014
Volume
2014
Pages
1-2
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W1976718809
Cited by
122
References
0
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammatory Reaction in Neurological Diseases. https://app.cochat.ai/papers/10.1155/2014/408514
The paper
Wang, H.-C., Lu, C.-H., Cheng, K.-I., & Chiang, J. C.-H. (2014). Inflammatory Reaction in Neurological Diseases. BioMed Research International. https://doi.org/10.1155/2014/408514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.